|
COPS8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.520000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.144820E-03 |
| Normal-vs-Stage2 |
4.015000E-01 |
| Normal-vs-Stage3 |
7.035000E-01 |
| Normal-vs-Stage4 |
9.884200E-01 |
| Stage1-vs-Stage2 |
3.507400E-01 |
| Stage1-vs-Stage3 |
6.190200E-02 |
| Stage1-vs-Stage4 |
1.892420E-01 |
| Stage2-vs-Stage3 |
3.985200E-01 |
| Stage2-vs-Stage4 |
5.761600E-01 |
| Stage3-vs-Stage4 |
8.258400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.003880E-03 |
| Normal-vs-AfricanAmerican |
7.002800E-01 |
| Normal-vs-Asian |
5.163000E-01 |
| Caucasian-vs-AfricanAmerican |
1.475850E-01 |
| Caucasian-vs-Asian |
8.312800E-01 |
| AfricanAmerican-vs-Asian |
7.327200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.167740E-04 |
| Normal-vs-Female |
8.833000E-01 |
| Male-vs-Female |
7.441100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.794970E-01 |
| Normal-vs-Extreme_Weight |
9.85190000000191E-05 |
| Normal-vs-Obese |
2.911600E-01 |
| Normal-vs-Extreme_Obese |
4.725800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.701000E-01 |
| Normal_Weight-vs-Obese |
7.173400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.200800E-01 |
| Extreme_Weight-vs-Obese |
8.036300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.125200E-01 |
| Obese-vs-Extreme_Obese |
9.073000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.270600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.199800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.04680000000157E-05 |
| Normal-vs-Age(81-100Yrs) |
2.007400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.454600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.177960E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.485000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.138300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.800200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.998600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.620700E-04 |
| Normal-VS-Type2 PRCC |
1.527990E-01 |
| Normal-VS-KIRP CIMP |
6.510400E-01 |
| Normal-VS-Unclassified PRCC |
4.782400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.242400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.322100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.680200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.872200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.955600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.156600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.338400E-01 |
| Normal-vs-N1 |
5.841600E-01 |
| Normal-vs-N2 |
9.317000E-01 |
| N0-vs-N1 |
2.209200E-01 |
| N0-vs-N2 |
1.979770E-01 |
| N1-vs-N2 |
6.321800E-01 |
|
|
